Transcend Medical Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 24
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $700M
Latest Deal Amount

Transcend Medical General Information

Description

Developer of minimally invasive devices designed for the treatment of glaucoma. The company's devices intend to replace current invasive therapies for glaucoma treatment with a significantly less invasive procedure using a novel, proprietary stent-based system to reduce intraocular pressure, enabling physicians to treat glaucoma, the leading cause of adult irreversible blindness.

Contact Information

Formerly Known As
iART Newco I
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Acquirer
Primary Office
  • 127 Independence Drive
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Transcend Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 18-Feb-2016 $700M 000.00 00000 Completed Generating Revenue
6. Later Stage VC (Series C) 05-Jan-2015 000.00 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series B) 14-Jul-2011 0000 000.00 000.00 Completed Generating Revenue
4. Early Stage VC (Series A1) 10-Nov-2006 00.000 00.00 000.00 Completed Startup
3. Early Stage VC (Series A) 20-Oct-2005 00.00 00.00 00.000 Completed Startup
2. Accelerator/Incubator 01-Jan-2005 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Transcend Medical’s complete valuation and funding history, request access »

Transcend Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 6,445,454 $0.001000 $0.09 $1.1 $1.1 1x $0.95 5.3%
Series A 3,999,999 $0.001000 $0.05 $0.6 $0.6 1x $0.6 2.84%
To view Transcend Medical’s complete cap table history, request access »

Transcend Medical Executive Team (6)

Name Title Board Seat Contact Info
Ravi Pamnani Director, Marketing & Medical Affairs
Tsontcho Ianchulev MD Chief Medical Officer
You’re viewing 2 of 6 executive team members. Get the full list »

Transcend Medical Board Members (10)

Name Representing Role Since
Reza Zadno Ph.D Self Chairman 000 0000
You’re viewing 1 of 10 board members. Get the full list »

Transcend Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Transcend Medical Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Canaan Partners Venture Capital Minority 000 0000 000000 0
Finistere Ventures Venture Capital Minority 000 0000 000000 0
ForSight Labs Accelerator/Incubator Minority 000 0000 000000 0
HLM Venture Partners Venture Capital Minority 000 0000 000000 0
Kaiser Permanente Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »